Novel drug regimens are needed for tuberculosis (TB) treatment. New regimens aim to improve on characteristics such as duration, efficacy, and safety profile, but no single regimen is likely to be ideal in all respects. By linking these regimen characteristics to a novel regimen’s ability to reduce TB incidence and mortality, we sought to prioritize regimen characteristics from a population-level perspective.
Original Source [2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/priority-setting-novel-drug-regimens-treat-tuberculosis-epidemiologic-model
[2] http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002202
[3] http://admin.indiaenvironmentportal.org.in/category/author/emily-kendall
[4] http://admin.indiaenvironmentportal.org.in/category/author/sourya-shrestha
[5] http://admin.indiaenvironmentportal.org.in/category/author/ted-cohen-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/plos-medicine
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tuberculosis
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/epidemics
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/south-africa
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/brazil
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/philippines
